Ten years of clinical trial data cannot legally be hidden from the public, US court rules
BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m832 (Published 02 March 2020) Cite this as: BMJ 2020;368:m832- Owen Dyer
- Montreal, Canada
US public health watchdogs have been failing for years in their legal duty to inform the public about the results of clinical trials, a federal court has found.
The US district court for southern New York ruled that an exemption granted by the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) that allowed hundreds of studies to escape reporting requirements laid down by Congress was unlawful.1
Transparency advocates hailed the ruling but expressed concern that its impact could be limited, as the court said it lacked the power to compel the FDA and NIH to enforce existing laws on disclosure of trial results, which to date they have been reluctant to do.
Legislation passed in 1997 required the government to set up the website ClinicalTrials.gov, to promulgate results from clinical trials of products approved to treat serious diseases. But with no …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.